Mural Oncology – Talk Bio

Actionable Insights Powered by AI

Mural risks going to the wall as IL-2 flop triggers 90% staff reduction, hunt for strategic alternatives

Interleukin-2, Mural Oncology, Mural, strategic alternatives, Nemvaleukin Alfa, 90%